Blake Schultz, MD
Orthopaedic Trauma · Austin, TXNPI 1669835799
Payments from drug & device makers
What this record shows
The money is spread across several categories — grants (26.9%), education and travel and lodging — rather than concentrated in one kind of arrangement. 11 manufacturers reported payments, led by Arthrex at 39.1% of the total. Reporting peaked in 2021 at $14,718 and has fallen 73.0% since, to $3,975 in 2025.
Across 126 payments — averaging $294.84 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Arthrex$15K
- Smith+Nephew$13K
- Osteocentric Technologies, Inc.$4K
- Medinc Of Texas$2K
- Stryker$2K
- Johnson & Johnson$599
- plus $551 from 5 others
What the payments were for
- Consulting fees$2,4757%
- Grants$10,00027%
- Travel & lodging$8,16522%
- Food & beverage$6,65918%
- Education$9,85027%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Arthrex | 19 | $14,535 |
| Smith+Nephew | 31 | $13,162 |
| Osteocentric Technologies, Inc. | 9 | $3,737 |
| Medinc Of Texas | 10 | $2,289 |
| Stryker | 37 | $2,277 |
| Johnson & Johnson | 12 | $599 |
| Globus Medical | 3 | $328 |
| Biocomposites Inc | 1 | $89 |
| Core Surgical Group | 1 | $81 |
| Ossur Americas, Inc. | 2 | $37 |
| Exactech, Inc. | 1 | $16 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- EVOS$6,254
- OsteoCentric 4.0 x 130mm LOCKING BONE SCREW FASTENER ST$3,636
- EVOS MINI$3,087
- TRIGEN$3,087
- TRIGEN InterTAN$670
- TRIGEN Meta-Nail$605
- TWINFIX$553
- Cadence$430
- T2$420
- AXSOS$281
- GAMMA$273
- NA$266
- Distal Femur Plate System$252
- VA-LCP$218
- PRO$169
- HYDROSET$156
- TFN-Advance$150
- VARIAX$134
How this compares
$37,150 in reported general payments places this provider in the 65th percentile of 74 orthopaedic trauma providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 67 | $259 |
| Tramadol Hcl | 65 | $158 |
| Gabapentin | 15 | $157 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 24 | $109 |
| Meloxicam | 82 | $92 |
| Ondansetron Hcl | 24 | $74 |
| Methocarbamol | 20 | $66 |
Paid to pharmacies, not to this prescriber.
Other orthopaedic trauma in Austin
- Vilas SaldanhaAustin$25K
- Mark ParrellaAustin$21K
- David LavertyAustin$17K
- Blake TurveyAustin$14K
- Austin HillAustin$10K
- Cody AndersonAustin$3K
- Cory CollingeFort Worth$2.8M
- John MunzHouston$1M
- Kyle DicksonHouston$975K
- Timothy AchorHouston$561K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.